Related Experiment Video
Updated: Jan 3, 2026

06:32
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
27.5K
Significant advances in veterinary oncology - 60 years on
1Department of Veterinary Medicine, University of Cambridge, Cambridge, CB3 0ES, UK.
The Journal of Small Animal Practice
|November 20, 2019
Summary
Veterinary oncology has advanced significantly over 60 years, improving cancer understanding, diagnosis, and treatment in animals. However, knowledge gaps and weak evidence bases persist, particularly due to limited randomized clinical trials.
Area of Science:
- Veterinary Medicine
- Oncology
- Comparative Pathology
Background:
- The Journal of Small Animal Practice (JSAP) published its first edition in February 1960, featuring a paper on malignant neoplasia treatments.
- This 60th anniversary provides an opportunity to review the evolution of veterinary oncology since that initial publication.
- Veterinary oncology has transformed into a multidisciplinary specialty with global networks.
Purpose of the Study:
- To provide a historical perspective on the advancements in veterinary oncology over the past 60 years.
- To highlight progress in understanding cancer pathology and epidemiology in animals.
- To review developments in the diagnosis and treatment of animal cancers.
Main Methods:
- Historical review of veterinary oncology literature and practice.
- Comparative analysis of early and current approaches to animal cancer management.
- Identification of knowledge gaps and limitations in the evidence base.
Main Results:
- Significant progress has been made in understanding animal cancer pathology and epidemiology.
- Diagnostic and therapeutic modalities for animal cancers have substantially improved.
- The field has become highly specialized, supported by international collaborations.
Conclusions:
- Veterinary oncology has seen remarkable advancements, enhancing animal cancer care.
- Despite progress, substantial knowledge gaps remain in the field.
- The evidence base for current standard-of-care treatments is often weak, necessitating further research, particularly randomized clinical trials.
Related Concept Videos
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
907
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
907
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

